References
- Hamil R J, Maki D G. Endotoxin shock in man caused by gram-negative bacilli. Etiology, clinical features, diagnosis, natural history and prevention. Handbook of endotoxin, R A Proctor. Elsevier, Amsterdam 1986; vol IV: 55–126
- Ziegler E J, McCutchan J A, Fierer J, Glauser M P, Sadoff J, Douglas H, Braude A I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant of Escherichia coli. N Engl J Med 1982; 307: 1225–1230
- Baumgartner J, Glauser M, McCutchan J A, Ziegler E J, Melle G, Klauber M R, Vogt M, Muehlen E, Lüthy R, Chiolero R, Geroulanos S. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet 1985; 2: 59–63
- Proctor R A. Role of antibody in the prevention and pathogenesis of endotoxin and gram-negative septic shock. Handbook of endotoxin, R A Proctor. Elsevier, Amsterdam 1986; vol IV: 55–126
- Gaffin S L. New therapeutic possibilities with anti-endotoxin antibodies. Hematol Blood Transfus 1985; 29: 107–111
- Marget W, Mar P J, Jaspers L, Possinger K, Haslberger H. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection 1985; 13: 120–124
- Werdan K, Piltz G, Kääb S. Haemodynamic effects during treatment of sepsis and septic shock with immunoglobulins and plasmapheresis. Second Vienna Shock Forum. Alan R. Liss, New York 1988; 10–16
- Fomsgaard A, Dinesen B, Bask L. Anti-lipopolysaccharide antibodies measured by enzyme-immunoassay in Danish blood donors. Acta Pathol Microbiol Immunol Scand (C) 1987; 95: 9–13
- Fomsgaard A, Zhang G-H, Shand G H, Bendtzen K, Bæk L. Immunochemical and biological reactivity of human anti-lipopolysaccharide IgG obtained by screening of blood donors. Scand J Immunol 1989; 29: 309–316
- Fomsgaard A, Galanos C. Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharides. APMIS, In press
- Fomsgaard A, Dinesen B. ELISA for IgG and IgM anti-lipopolysaccharide antibodies with indirect standardization. J Immunoassay 1987; 8: 333–350
- Fomsgaard A, Feldt-Rasmussen B, Deckert M, Dinesen B. Micro-ELISA for the quantitation of human urinary IgG. Scand J Clin Lab Invest 1987; 47: 195–198
- Bæk L. New, sensitive rocket-immunoelectrophoretic assay for measurement of the reaction between endotoxin and Limulus amoebocyte lysate. J Clin Microbiol 1983; 17: 1013–1020
- Fomsgaard A, Worsaa H, Bendtzen K. Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 1988; 27: 143–147
- Knaus W A, Draper E A, Wagner D P, Zimmerman J E. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–829
- Fomsgaard A, Nielsen R, Froberg K D, Beck L, Deghn H K. Endotoxinemia in toxic shock syndrome treated with anti-endotoxin antibodies. Lancet 1987; 1: 514–515
- McCartney A C, Piotrowicz B I, Edlin S, Ledngham IMcA. Measurement of endotoxin in the acute phase of septic shock. Bacterial endotoxins: Pathophysiological effects. clinical significance, and pharmacological control, J Levin, H R Büller, J W Ten Cate, S JH van Deventer, A Sturk. Alan R. Liss, New York 1988; 225–236
- van Deventer S JH, Buller H R, ten Cate J W, Sturk A, Pauw W. Endotoxaemia: An early predictor of septicemia in febrile patients. Lancet 1988; 2: 605–609
- Galanos C, Freudenberg M A, Coumbos A, Matsuura M, Lehmann V, Bartholeyns J. Induction of lethality and tolerance by endotoxin are mediated by macrophages through tumor necrosis factor. Tumor necrosis factor/cachectin and related cytokines. Int Conf Tumor Necrosis Factor and Related Cytokines, Heidelberg 1987, Giford Bonevida, Old Kirchner. Karger, Basel 1988; 114–127
- Cuevas P, Fine J. Route of absorption of endotoxin from the intestine in non-septic shock. J Reticuloendothel Soc 1972; 11: 535–538
- Duncan R L, Morrison D C. The fate of E. coli lipopolysaccharides after the uptake of E. coli by murine macrophages in vitro. J Immunol 1984; 132: 1416–1424
- Piltz G, Stablein A, Reuschel-Janetschek E, Autenrieth, Werdan K. The use of scoring systems in patients with cardiogenic and septic shock. Second Vienna Shock Forum, G Schlag, H Redl. Alan R. Liss, New York 1988
- Young L S, Armstrong D. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leucocytes, and serum factors. J Infect Dis 1972; 126: 257–276